Tosoh Bioscience Application Note
Cellulose acetate (CA) is one of the most important cellulose derivatives. Its main applications are their use in membranes, films, fibres, plastics and filters. The chemical and physical properties of these derivatives are strongly influenced by the degree of substitution (DS) and the molar mass and molar mass distribution. Therefore, there is a strong need to characterize these properties.
SEC provides a convenient way for the characterization of molar masses and molar mass distribution of synthetic and natural polymers. However, a crucial balance of the polarities of the analyte, the solvent and the stationary phase is required for a reliable SEC method. Since DS of cellulose derivatives alters the polarity, solubility and aggregation behaviour, the SEC methods found in literature are usually valid only within a narrow DS-range. Published SEC methods usually apply THF or DMF modified by the addition of LiBr as eluents on styrene-divinylbenzene (SDV) columns. However, often neither the degree of substitution nor the DS-range applicable for the given chromatographic conditions are specified. The only SEC system suitable for cellulose acetate over a wide DS-range (DS range 0.4-1.2) uses pyridine/water on a GRAMS column. This application note reports on SEC-separations of high molar mass CAs for CAs of higher DS in the range DS = 1.5-3.
Most samples were prepared by partial saponification of a commercial CA sample with a DS of 2.6. Other samples were of industrial origin. A Tosoh Biosystems EcoSECSystem (Tosoh, Stuttgart, Germany) equipped with a MALLS detector (DAWN DSP, Wyatt Technology, Santa Barbara, USA) was used. The stationary phase was a GRAM linear XL column (10 µm particle size, 30 × 0.8 cm, PSS Polymer Standards Service, Mainz, Germany). DMSO was used as the eluent. The low refractive index increment of cellulose acetates in DMSO (0.024-0.044 mL/g, depending on DS) does not allow for reliable molar mass determination by SEC-MALLS. The very sensitive EcoSEC RI, however, could easily detect those samples reliably. However, the light scattering instrument revealed aggregation if no or only low LiCl concentrations were used. Aggregation was not observed at LiCl concentrations above 50 mmol/L. Some of the samples required higher salt concentrations for dissolution.
Figure 1 shows a comparison of the chromatograms of three CAs of different DS, which were prepared from the same base material. The elution volumes and the peak shapes of the samples are nearly identical, indicating that no degradation occurred during saponification. This has also been confirmed by molar mass determination using light scattering in a different solvent with higher sample contrast (dn/dc). The close agreement in the chromatograms of the samples can therefore be regarded as an indication of nearly identical calibration curves of the cellulose acetates despite differences in DS. The fourth sample of DS = 1.72 is a commercial sample. It is presented in order to show that the close agreement of the chromatograms is not due to an insufficient chromatographic resolution. The independence of the calibration curves on DS is advantageous. It will allow reliable molar mass determination of cellulose acetates without worrying about variations of SEC elution volume due to differences in DS.
Figure 1: Stacked overlay of chromatograms of cellulose acetates of different DS: DS (grey: DS = 2.45, red: DS = 2.09, green: DS = 1.59) derived from the same base material by partial saponification and a commercial sample (blue: DS = 1.72).
Zettachrgin 6, 70567 Stuttgart, Germany
tel:+49 (0)711 13257-0
fax:+49 (0)711 13257-89
E-mail: info.tbg@tosoh.com
Website: www.tosohbioscience.com
1. Soo-Jung Lee et al., Carbohydrate Polymers, 54, 353-362. (2003)
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.